Biosimilars undergo rigorous comparison with their reference product to ensure pharmacokinetic (PK) and pharmacodynamic similarities, immunogenicity, and efficacy, but any data limitations must be ...

Alkem Oncology has launched Cetuxa, the world’s first biosimilar of Cetuximab used for the treatment of head and neck cancer. Cetuxa has been researched and manufactured indigenously by Enzene ...

China’s National Medical Products Administration authorized the country’s first cetuximab biosimilar with the approval of Simcere Zaiming’s Enlituo (CMAB-009, cetuximab beta injection) in combination ...

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress ...

The activity and safety of adagrasib plus cetuximab in patients with colorectal cancer with mutated KRAS G12C is being evaluated in the ongoing phase 3 KRYSTAL-10 trial as second-line treatment as ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...